Aims:

The primary aim of this study is to develop a value set for the EQ-5D-5L health states based on the preferences of the Qatari general population.

Secondary aims are to:

1) Examine the construct validity of the EQ-5D-5L instrument in Qatar general adult population.

2) Develop population norms for the EQ-5D-5L.

3) Identify determinants of preferences in the Qatari population.

4) Explore the impact of culture and religion on completing preference elicitation exercises; and

5) Compare value sets derived from cTTO-based, hybrid, and DCE with duration (DCEd) methodologies, in order to assess the consistency and agreement among these valuation approaches.

Methods:

This will be a cross-sectional population-based study involving interviewer-administered in person or online interviews following the EuroQol EQ-5D-5L valuation protocol and using the EuroQol Valuation Technology (EQ-VT).

A sample of 1150 adults will be recruited from the Qatari general population using a two-stage quota sampling.

Interviews will be conducted by trained research assistants who will undergo a 3-day training and will take place at a private and convenient settings depending on the participant’s preferences.

EuroQol quality control processes will be followed to ensure high quality data.

Learn more about the EQ-5D Instrument

EQ-5D-5L Study in Qatar Registration Form

Thank you for considering registering for our upcoming EQ-5D-5L Study in Qatar. We invite you to participate in a study exploring how people in Qatar perceive different health and illness states. If you are eligible, we will reach out to you with further details on the study and proceed with the interview process, which will take approximately 45 minutes to complete. To thank you for your time and contribution in the study, you will receive a 120 QAR gift card. The voucher may be provided either electronically or in physical form, depending on whether the interview is conducted online or in person.

Full Name:*
Phone Number*
Email Adress*
Birthday Date*
Are you an adult aged 18 years or older?
- Yes
- No
Are you a Qatari national OR a non-Qatari who has resided in Qatar for at least 5 years?
- Yes
- No
Are you able to complete the survey in Arabic or English?
- Yes
- No
Do you consent to being contacted for participation in the EQ-5D-5L Study?
- Yes, I consent
- No, I do not consent

Email Adress or Phone Number

Principal Investigators

Fatima Al Sayah, PhD

Center for Clinical, Health Economics and Outcomes Research (CCHO) Dubai, Al Razi Building, Floor 5, Dubai HealthCare City, United Arab Emirates

Anas Hamad, PhD

Hamad Medical Corporation, Qatar University principal investigator

EQ-5D-5L Valuation Study in UAE

Co-investigators:

Dr. Marcel Jonker , PhD, EuroQol Research Foundation

Dr. Christiane Maskineh, PhD, CEO CCHO.

Dr. Mirna Matni, PharmD, MSC Tox, Director P&R & Health Policy Insights, CCHO.

Study Coordinator

Youmna Bassil (CCHO)
Caline Saade (CCHO)

Duration of Project ( months)

18 months

EQ-5D-5L Valuation Study in Qatar